Binlei Liu

3.2k total citations · 1 hit paper
70 papers, 2.4k citations indexed

About

Binlei Liu is a scholar working on Genetics, Oncology and Epidemiology. According to data from OpenAlex, Binlei Liu has authored 70 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 28 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Binlei Liu's work include Virus-based gene therapy research (39 papers), CAR-T cell therapy research (24 papers) and Viral Infectious Diseases and Gene Expression in Insects (16 papers). Binlei Liu is often cited by papers focused on Virus-based gene therapy research (39 papers), CAR-T cell therapy research (24 papers) and Viral Infectious Diseases and Gene Expression in Insects (16 papers). Binlei Liu collaborates with scholars based in China, United Kingdom and United States. Binlei Liu's co-authors include Paul R. Lambden, Ian N. Clarke, Suzanne Thomas, R. S. Coffin, Maureen Thornton, Yvonne McGrath, C English, Christopher Love, Philip A. Reay and Max Robinson and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Binlei Liu

67 papers receiving 2.3k citations

Hit Papers

ICP34.5 deleted herpes simplex virus with enhanced oncoly... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
    2003 628 citations Binlei Liu, Max Robinson et al. Gene Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binlei Liu China 24 1.1k 890 814 640 474 70 2.4k
Sarah K. Wootton Canada 26 781 0.7× 297 0.3× 715 0.9× 487 0.8× 582 1.2× 108 2.1k
Cathy L. Miller United States 27 513 0.5× 880 1.0× 748 0.9× 618 1.0× 312 0.7× 52 2.2k
Jerome Custers Netherlands 19 1.3k 1.2× 539 0.6× 757 0.9× 1.1k 1.6× 103 0.2× 33 2.2k
Oliver Wildner Germany 25 1.1k 1.1× 663 0.7× 265 0.3× 1.0k 1.6× 106 0.2× 61 2.0k
Akira Nishizono Japan 28 432 0.4× 172 0.2× 941 1.2× 482 0.8× 172 0.4× 169 3.0k
Luca Ceccherini‐Nelli Italy 26 441 0.4× 665 0.7× 500 0.6× 336 0.5× 289 0.6× 71 2.2k
Maria A. Croyle United States 24 1.3k 1.2× 412 0.5× 800 1.0× 1.2k 1.9× 83 0.2× 55 2.2k
Bernardo A. Mainou United States 22 409 0.4× 369 0.4× 754 0.9× 393 0.6× 141 0.3× 58 1.5k
Toru Takimoto United States 34 561 0.5× 286 0.3× 1.2k 1.5× 703 1.1× 389 0.8× 133 3.8k
Colomba Giorgi Italy 29 361 0.3× 185 0.2× 687 0.8× 680 1.1× 161 0.3× 63 2.3k

Countries citing papers authored by Binlei Liu

Since Specialization
Citations

This map shows the geographic impact of Binlei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binlei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binlei Liu more than expected).

Fields of papers citing papers by Binlei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binlei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binlei Liu. The network helps show where Binlei Liu may publish in the future.

Co-authorship network of co-authors of Binlei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Binlei Liu. A scholar is included among the top collaborators of Binlei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binlei Liu. Binlei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Zhengfu, Han Liang, Suxia Luo, et al.. (2025). Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial. Journal for ImmunoTherapy of Cancer. 13(1). e010543–e010543. 3 indexed citations
2.
Zhang, Hui, Le Li, Xinya Wang, et al.. (2024). VP5 protein of oncolytic herpes simplex virus type 2 induces apoptosis in A549 cells through TP53I3 protein. Virology. 595. 110093–110093. 3 indexed citations
3.
Ren, Ge, et al.. (2024). Exploring immune evasion of SARS-CoV-2 variants using a pseudotyped system. Heliyon. 10(8). e29939–e29939. 1 indexed citations
4.
Hu, Han, Fan Yi, Yanxia Li, et al.. (2023). Preclinical safety assessment of an oncolytic herpes simplex virus type 2 expressed PD-L1/CD3 bispecific antibody. International Immunopharmacology. 124(Pt B). 110975–110975. 2 indexed citations
5.
Zhang, Zhihao, Bing Hu, Qian He, et al.. (2023). PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application. npj Vaccines. 8(1). 38–38. 2 indexed citations
6.
7.
Kan, Xuefeng, Xiaopeng Guo, Tao Ouyang, et al.. (2022). Transarterial viroembolization improves the therapeutic efficacy of immune-excluded liver cancer: Three birds with one stone. Pharmacological Research. 187. 106581–106581. 4 indexed citations
8.
9.
Wang, Yang, Jing Jin, Yuying Li, et al.. (2021). NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors. Translational research. 240. 64–86. 24 indexed citations
10.
Hu, Han, et al.. (2020). BGC823 Cell Line with the Stable Expression of iRFP720 Retains Its Primary Properties with Promising Fluorescence Imaging Ability. DNA and Cell Biology. 39(5). 900–908. 1 indexed citations
11.
Zhang, Wen, Xiao Hu, Jing Liang, et al.. (2020). oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity. Molecular Therapy — Oncolytics. 16. 158–171. 22 indexed citations
12.
13.
Hu, Xiao, Lin Feng, Zhenrong Yang, et al.. (2019). Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1. Molecular Therapy — Oncolytics. 15. 201–213. 22 indexed citations
14.
Yang, Tieshan, Qian Yao, Fei Cao, et al.. (2016). Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis. International Journal of Nanomedicine. Volume 11. 6679–6692. 95 indexed citations
15.
Zhou, Chunxia, et al.. (2013). Antitumor enhancement by adoptive transfer of tumor antigen primed, inactivated MHC-haploidentical lymphocytes. Cancer Letters. 343(1). 42–50. 9 indexed citations
16.
Liu, Binlei, Wei Zhang, Xiang Zhang, et al.. (2010). Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas. Neuro-Oncology. 12(6). 540–548. 61 indexed citations
17.
Liu, Binlei, Max Robinson, C English, et al.. (2003). ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Therapy. 10(4). 292–303. 628 indexed citations breakdown →
18.
Liu, Binlei, et al.. (2000). Production of Cyclodepsipeptides Destruxin A and B from Metarhizium anisopliae. Biotechnology Progress. 16(6). 993–999. 23 indexed citations
19.
Liu, Binlei, et al.. (1997). Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers.. Environmental Health Perspectives. 105(suppl 5). 1069–1072. 37 indexed citations
20.
Liu, Binlei, Ian N. Clarke, E O Caul, & Paul R. Lambden. (1997). The Genomic 5′ Terminus of Manchester Calicivirus. Virus Genes. 15(1). 25–28. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah K. Wootton Breakdown of academic impact, for papers by Cathy L. Miller Breakdown of academic impact, for papers by Jerome Custers Breakdown of academic impact, for papers by Oliver Wildner Breakdown of academic impact, for papers by Akira Nishizono Breakdown of academic impact, for papers by Luca Ceccherini‐Nelli Breakdown of academic impact, for papers by Maria A. Croyle Breakdown of academic impact, for papers by Bernardo A. Mainou Breakdown of academic impact, for papers by Toru Takimoto Breakdown of academic impact, for papers by Colomba Giorgi
Rankless by CCL
2026